Biosimilar Competition In The United States: Statutory Incentives, Payers, And Pharmacy Benefit Managers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biosimilar Competition In The United States: Statutory Incentives, Payers, And Pharmacy Benefit Managers

Published:2015-02 Issue:2 Volume:34 Page:294-301
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Falit Benjamin P.¹,Singh Surya C.²,Brennan Troyen A.³

Affiliation:

1. Benjamin P. Falit ( ) is a resident physician in the Harvard Radiation Oncology Program, in Boston, Massachusetts.

2. Surya C. Singh is the corporate vice president of specialty client solutions and trend management at CVS Health in Lincoln, Rhode Island.

3. Troyen A. Brennan is the chief medical officer at CVS Health in Woonsocket, Rhode Island.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference7 articles.

1. Biosimilars And The European Experience: Implications For The United States

2. Biosimilar competition: lessons from Europe

3. The Market For Follow-On Biologics: How Will It Evolve?

4. Regulatory And Cost Barriers Are Likely To Limit Biosimilar Development And Expected Savings In The Near Future

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking the medication management of major depression;Expert Review of Neurotherapeutics;2023-04-03

2. Patenting and patent challenges in South Korea after introducing a patent linkage system;Globalization and Health;2022-11-12

3. Biosimilar competition: Early learning;Health Economics;2022-01-12

4. Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians;BioDrugs;2021-11-25

5. Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative;Journal of Managed Care & Specialty Pharmacy;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3